Air Quality & it’s impact on Idiopathic Pulmonary Fibrosis (IPF) patients
by Eamonn Costello | Back to Blog
We’re glad to see research from Johannson et al on impact of air pollution on Idiopathic Pulmonary Fibrosis (IPF) patients. Their research looked at home spirometry data and symptom diaries from 25 patients and used their residential address to estimate the weekly mean air pollution exposures from ozone (O3), nitrogen dioxide (NO2), and particulate matter (PM2.5 and PM10).
Their research found that higher air pollution exposures were associated with lower lung function, but not changes in lung function.
The research outlines the need for further work in this area. patientMpower has the capability to help provide the data to power this research.
Our patient App is used across the world and has recorded more than 10,000 home spirometry readings, with associated (outdoor) Air Quality data from their nearest air quality monitoring station.
This data forms part of our digital biobank, a rich phenotype data-set characterizing a range of objective (e.g. spirometry), subjective (e.g mMRC) and other data-sets including Geo-medicine, how your location affects your health status. Air Quality is an important part of how your location affects your health.
The patientMpower app shows the local air quality to our users so they can make informed decision about exercising outdoors. The app displays the Air Quality Index, and internationally used scale which uses different factors to categorize the air quality as anything from Good to Hazardous.
For an overall view of Air Quality in the USA, please see the American Lung Association’s State of the Air 2018 report.